Abstract
Epstein-Barr virus (EBV) encoded latent membrane protein 1 (LMP1) is considered as the major oncogenic protein of EBV encoded proteins, which could transactivate many transcription factors including activator protein 1 (AP-1). Transcription factor plays its role in biological effects through binding to the target gene promoter, transactivating the transcription of target gene, regulating the target gene expression, etc. Recently, we found that LMP1 could mediate a new heterodimer form of c-Jun and JunB, which could bind to AP1 DNA sequence. In this report, we confirmed p16 as a putative target gene of c-Jun/JunB using bioinformatics. We used Tet-on-LMP1 HNE2 cell line as a cell model, which is a dual-stable LMP1 integrated HNE2 cell line and the expression of LMP1 could be regulated by the Tet system, and we wanted to explore whether c-Jun/JunB heterodimers mediated by LMP1 could regulate p16. Data demonstrated that c-Jun/Jun B heterodimers mediated by LMP1 downregulated both the promoter activity and p16 expression, and accelerated the cell cycle progression. These findings established a new direct connection between the AP-1 singnal pathway and the cell cycle, and provided a new model for the carcinogenesis mechanism.
Similar content being viewed by others
References
Eliopoulos, A. G., Young, L. S., Activation of the c-Jun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein1 (LMP1), Oncogene, 1998, 16: 1731–1742.
Vogt, P. K., Jun, the oncoprotein, Oncogene, 2001, 20: 2365–2377.
Leaner, V. D., Kinoshita, I., Birrer, M. J., AP1 complexes containing c-Jun and JunB cause cellular transformation of ratla fibroblasts and share transcriptional targets, Oncogene, 2003, 28: 5619–5629.
Liao, W., Yi, H., Cao, Y. et al., Doxycycline dependent expression of EBV latent membrane protein 1 with Tet regulating system in NPC cell line, Acta Biochemica et Biophysica Sinica, 1999, 31: 309–312.
Luo, F. J., Peng, X. N., Li, X. Y. et al., Epstain-Barr virus LMP1 upregulates activity of AP-1 in nasopharyngeal cell line, Chinese Journal of Biochemistry and Molecular Biology, 2000, 16: 551–555.
Tang, F. Q., Tang, M., Xia, L. Q. et al., Study of apoptosis regulated by Epstein-Barr virus encoded latent membrane protein 1 using apoptosis cDNA expression array, Chinese Journal of Virology, 2001, 17: 97–102.
Hu, Z., Luo, F. J., Zeng, L. et al., Inhibitory effect of JIP on AP-1 activity induced by LMP1 in nasopharyngeal carcinoma cells and its mechanism Chinese Journal of Pathophysiology, 2002, 18: 1169–1172.
Finch, S., Joseloff, E., Bowden, T., JunB negatively regulates AP1 activity and cell proliferation of malignant mouse keratinocytes, J. Cancer Res. Clin. Oncol., 2002, 128: 3–10.
Hu, Z., Zheng, L., Tao, Y. G. et al., EB virus-encoded latent membrane protein 1 activates the JNK signaling pathway via a mechanism involving TRADD and TRAF in nasopharyngeal carcinoma cell, Prog. Biochem. Biophys., 2002, 29: 562–566.
Song, X., Tao, Y. G., Cao, Y. et al., Heterodimers formation between c-Jun and Jun B proteins mediated by Epstein Barr virus encoded latent membrane protein 1, Science in China, Ser.C, 2004, accepted.
Passegue, E., Wagner, E. F., JunB cell proliferation by transcriptional activation of p16INK4a expression, EMBO J., 2000, 19: 2969–2979.
Sun, Y., Hildesheim, A., Lanier, A. E. et al., No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas, Oncogene, 1995, 10: 785–788.
Gulley, M. L., Nicholls, J. M., Schneider, B. G. et al., Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product, Am. J. Pathol., 1998, 152: 865–869.
Makitie, A. A., MacMillan, C., Ho, J. et al., Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma, Clin. Cancer Res., 2003, 9: 2177–2184.
Chang, H. W., Chan, A., Kwong, D. L. et al., Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient, Int. J. Cancer, 2003, 105: 851–855.
Wang, G. L., Lo, K. W., Tsang, K. S. et al., Inhibiting tumorigenic potential by restoration of p1 6 in nasopharyngeal carcinoma, British Journal of Cancer, 1999, 81: 1122–1126.
Zuo, Y., Yi, H., Gu, H. H. et al., Alterations of the p16 gene in nasopharyngeal carcinogenesis, Chinese Medical Journal (in English), 2000, 113: 48.
Donjerkovic, D., Scott, D. W., Regulation of the G1 phase of the mammalian cell cycle, Cell Res., 2000, 10: 1–16.
Song, X., Cao, Y., Regulation of G1/S phase checkpoint and multistep carcinogenesis, Frogein Medical Science (Molecular Biology Section), 2002, 24: 73–76.
Ausubel, F. M., Roger, B., Kingston, R. E. et al., Current Protocols in Molecular Biology, Vol. 4, New York: John Wiley & Sons, Inc. Press, USA, 2001.
Andrews, N. C., Faller, D. V., A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells, Nucleic Acids Research, 1991, 19: 2499.
Bakiri, L., Lallemand, D., Ella, B. W. et al., Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression, EMBO J., 2000, 19: 2056–2068.
Briggs, M. R., Kadonaga, J. T., Bell, S. P. et al., Purification and biochemical characterization of the promoter-specific transcription factor, Sp1, Science, 1986, 234: 47–52.
Hara, E., Smith, R., Parry, D. et al., Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence, Mol. Cell Biol., 1996, 16: 859–867.
Chapman, N. R., Perkins, N. D., Inhibition of the RelA (p65) NF-kappaB subunit by Egr-1, J. Biol. Chem., 2000, 275: 4719–4725.
Deng, T., Karin, M., JunB differs from c-Jun in its DNA-binding anddimerization domains, and represses c-Jun by formation of inactive heterodimers, Genes Dev., 1993, 7: 479–490.
Szabowski, A., Maas-Szabowski, N., Andrecht, S. et al., c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin, Cell, 2000, 103: 745–755.
Wang, G. L., Lo, K. W., Tsang, K. S. et al., Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma, British Journal of Cancer, 1999, 81(7): 1122–1126.
Lee, A. W., Li, J. H., Shi, W. et al., p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma, Mol. Cancer Ther., 2003, 2: 961–969.
Liao, W., Tang, M., Deng, X. Y. et al., Epstein-Barr virus encoded latent membrane protein 1 promotes nuclear factor-kappa B activity in a nasopharyngeal carcinoma cell line, Chinese Journal of Virology (in Chinese), 2000, 16: 198–202.
Luo, F. J., Hu, Z., Zeng, L. et al., Experimental study on transcriptional regulation of malignant progression in nasopharyngeal carcinoma by EPSTEIN-BARR virus encoded latent membrane protein 1, Progress in Biochemistry and Biophysics (in Chinese), 2002, 29: 567–571.
Zhao, X. R., Deng, L., Weng, X. X. et al., Further study on cyclin D1 expression and function in human nasopgaryngeal carcinoma cell line, Chin. J. Oncol. (in Chinese), 2001, 23: 373–375.
Zhao, X. R., Wang, C. X., Luo, F. J. et al., The Epstein-Barr virus encoded latent membrane protein 1 (EBV-LMP1) activates expression of cyclinD1, Progress in Biochemistry and Biophysics (in Chinese), 2001, 28: 704–710.
Zhao, X. R., Gu, H. H., Weng, X. X. et al., The primary study on expression and function of D-Type cyclin in nasopharyngeal carci noma cell lines, Acta Biochimica et Biophysica Sinica (in Chinese), 2000, 32: 192–196.
Song, X., Cao, Y., Feedback mechanism of homeostasis in cell circuitry during multistage carcinogenesis, Frogein Medical Science (Cancer Section), 2001, 28: 407–409.
Gadd, M., Pisc, C., Branda, J. et al., Regulation of cyclin D1 and p16 is critical for growth arrest during mammary involution, Cancer Res., 2001, 61: 8811–8819.
Yang, C. C., Chu, K. C., Chen, H. Y. et al., Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression, Urol. Int., 2002, 69: 190–194.
Papadimitrakopoulou, V. A., Izzo, J., Mao, L. et al., Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development, Clin. Cancer Res., 2001, 3127–3134.
Sartor, M., Steingrimsdottir, H., Elamin, F. et al., Role of p16/ MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines, Br. J. Cancer, 1999, 80: 79–86.
Beasley, M. B., Lantuejoul, S., Abbondanzo, S. et al., The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung, Hum. Pathol., 2003, 34: 136–142.
Zhou, B. B., Elledge, S. J., The DNA damage response: putting checkpoints in perspective, Nature, 2000, 408: 433–439.
Lukas, J., Aagaard, L., Strauss, M. et al., Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control, Cancer Res., 1995, 55: 4818–4823.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Song, X., Ai, M., Chen, X. et al. Regulation of c-Jun/JunB heterodimers mediated by Epstein-Barr virus encoded latent membrane protein 1 on p16. Chin.Sci.Bull. 49, 676–683 (2004). https://doi.org/10.1007/BF03184264
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03184264